Armel Hyoubi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Armel Hyoubi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Adhideb Ghosh
Functional Genomics Center Zurich, ETH Zurich, and University of Zurich 3 , Zurich
1 shared publication - Ahmed Ghallab
Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
1 shared publication - Alessandro Annibaldi
University of Cologne, Cologne, Germany
1 shared publication - Ali Taleb Abdallah
Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
1 shared publication - Andreas Lindhorst
Institute of Anatomy, Leipzig University, Leipzig, Germany
1 shared publication - Anne Hoffmann
Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum Munich at the University of Leipzig and University Hospital Leipzig
1 shared publication
Latest Publications
- Open Access
- 19 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (38) , eadw2539
Linear ubiquitination prevents lipodystrophy and obesity-associated metabolic syndrome
Adipocyte hypertrophy during obesity triggers chronic inflammation, leading to metabolic disorders. However, the role of adipocyte-specific inflammatory signaling in metabolic syndrome remains unclear. The linear ubiquitin chain assembly complex, LUBAC, is an E3-ligase that generates nondegradative linear ubiquitination (Lin-Ub). LUBAC regulates NF-κB/MAPK-driven inflammation and prevents cell death triggered by immune receptors like TNF receptor-1. Here, we show that mice lacking HOIP, the Lin-E3 ligase catalytic subunit of LUBAC, in adipocytes ( Hoip A-KO ) display lipodystrophy and heightened susceptibility to obesity-induced metabolic syndrome, particularly metabolic dysfunction-associated steatotic liver disease (MASLD). Mechanistically, loss of HOIP attenuates TNF-induced NF-κB activation and promotes cell death in human adipocytes. Inhibiting caspase-8–mediated cell death is sufficient to prevent lipodystrophy and MASLD in Hoip A-KO obese mice. HOIP expression in adipose tissue positively correlates with metabolic fitness in obese individuals. Overall, our findings reveal a fundamental developmental role for Lin-Ub in adipocytes by mitigating cell death–driven adipose tissue inflammation and protecting against obesity-related metabolic syndrome.
- 19 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (38) , eadw2539
Open AccessLinear ubiquitination prevents lipodystrophy and obesity-associated metabolic syndrome
Adipocyte hypertrophy during obesity triggers chronic inflammation, leading to metabolic disorders. However, the role of adipocyte-specific inflammatory signaling in metabolic syndrome remains unclear. The linear ubiquitin chain assembly complex, LUBAC, is an E3-ligase that generates nondegradative linear ubiquitination (Lin-Ub). LUBAC regulates NF-κB/MAPK-driven inflammation and prevents cell death triggered by immune receptors like TNF receptor-1. Here, we show that mice lacking HOIP, the Lin-E3 ligase catalytic subunit of LUBAC, in adipocytes ( Hoip A-KO ) display lipodystrophy and heightened susceptibility to obesity-induced metabolic syndrome, particularly metabolic dysfunction-associated steatotic liver disease (MASLD). Mechanistically, loss of HOIP attenuates TNF-induced NF-κB activation and promotes cell death in human adipocytes. Inhibiting caspase-8–mediated cell death is sufficient to prevent lipodystrophy and MASLD in Hoip A-KO obese mice. HOIP expression in adipose tissue positively correlates with metabolic fitness in obese individuals. Overall, our findings reveal a fundamental developmental role for Lin-Ub in adipocytes by mitigating cell death–driven adipose tissue inflammation and protecting against obesity-related metabolic syndrome.